Over the past two months, Lorraine Johnson, CEO of LDO and Elizabeth (Betty) Maloney, MD, the International Lyme & Associated Diseases Society (ILADS), have analyzed the IDSA guidelines and prepared a 58-page rebuttal.
Their comments have been endorsed by more than 64 patient advocacy groups from 5 countries, including the national Lyme Disease Association Inc. and the Bay Area Lyme Foundation, as of August 28, 2019. LDO is an Affiliate of Lyme Disease Association, Inc.